Increased expression of microRNA miR-326 in type 1 diabetic patients with ongoing islet autoimmunity.
about
MicroRNAs: Novel Players in the Dialogue between Pancreatic Islets and Immune System in Autoimmune DiabetesRole of regulatory micro RNAs in type 2 diabetes mellitus-related inflammationMicroRNAs: new insights into chronic childhood diseasesMicroRNA regulation of lymphocyte tolerance and autoimmunityRisk factors and primary prevention trials for type 1 diabetesVitamin D and microRNAs in boneA Bioinformatics Approach to the Identification of Variants Associated with Type 1 and Type 2 Diabetes Mellitus that Reside in Functionally Validated miRNAs Binding Sites.miRNAs: novel regulators of autoimmunity-mediated pancreatic β-cell destruction in type 1 diabetes.Environmental exposures in utero and microRNA.Plasma fatty acid ratios affect blood gene expression profiles--a cross-sectional study of the Norwegian Women and Cancer Post-Genome Cohort.Prospects for Therapeutic Targeting of MicroRNAs in Human Immunological Diseases.MicroRNAs miR-23a-3p, miR-23b-3p, and miR-149-5p Regulate the Expression of Proapoptotic BH3-Only Proteins DP5 and PUMA in Human Pancreatic β-Cells.MicroRNA expression profiles identify disease-specific alterations in systemic lupus erythematosus and primary Sjögren's syndromeMiR-326 regulates cell proliferation and migration in lung cancer by targeting phox2a and is regulated by HOTAIR.Profiling of circulating microRNAs in children with recent onset of type 1 diabetes.Vitamin D, immune tolerance, and prevention of type 1 diabetes.Epigenetics in autoimmune diseases with focus on type 1 diabetes.MicroRNA control in the development of systemic autoimmunity.Candidate genes for type 1 diabetes modulate pancreatic islet inflammation and β-cell apoptosis.Molecular mechanisms in autoimmune type 1 diabetes: a critical review.microRNAs with different functions and roles in disease development and as potential biomarkers of diabetes: progress and challenges.Circulating miRNAs as biomarkers for endocrine disorders.Circulating microRNAs and diabetes: potential applications in medical practice.miRNAs: early prognostic biomarkers for Type 2 diabetes mellitus?Association of serum microRNAs with islet autoimmunity, disease progression and metabolic impairment in relatives at risk of type 1 diabetes.Epigenetic alterations underlying autoimmune diseases.Nucleic acid biomarkers of β cell stress and death in type 1 diabetes.Biomarkers of β-Cell Stress and Death in Type 1 Diabetes.MicroRNAs in Type 1 Diabetes: Complex Interregulation of the Immune System, β Cell Function and Viral Infections.Beyond Genetics: What Causes Type 1 Diabetes.Interplay between miRNAs and human diseases.Circulating microRNAs and diabetes mellitus: a novel tool for disease prediction, diagnosis, and staging?Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first-line oxaliplatin-based treatment.MicroRNA in Immune Regulation.MicroRNA expression profiles and type 1 diabetes mellitus: systematic review and bioinformatic analysis.MicroRNA-326 contributes to autoimmune thyroiditis by targeting the Ets-1 protein.Serum miRNA levels are related to glucose homeostasis and islet autoantibodies in children with high risk for type 1 diabetes.Expression and clinical significance of microRNA-326 in human glioma miR-326 expression in glioma.Exosomal MicroRNA-15a Transfer from the Pancreas Augments Diabetic Complications by Inducing Oxidative Stress.Circulating microRNAs in Diabetes Progression: Discovery, Validation, and Research Translation.
P2860
Q26784462-287E71E3-932C-492A-AFA9-14B0D41C72FAQ26830676-4362078F-2192-4E0D-BAFE-5F1043E1F29FQ26852909-53869232-C5BD-4764-B9D9-34DB62C57012Q26852975-3CD3F92B-5945-4198-80EE-C6CB732B4601Q27005625-A0E7E628-A74F-45AC-B136-CC458DBED499Q27015808-D0582142-6F4D-4D63-A18F-18A257DB20DAQ30383955-9CCEA689-0611-4379-AADF-5E12F82B172BQ33920162-9CB167C2-2AC4-42A7-8B76-94F7DD32BD47Q34252480-2A7BD30D-2643-4F4F-8E08-8A42B70325FEQ34794855-00075A17-5501-4C94-A16B-813604ECEC18Q35619546-017A0487-650C-4FA4-A4F0-45D9AA8110EBQ36163240-6F50CD13-1F3D-4790-8E68-13B4D906AC6EQ36322151-2CD19A76-9AC5-42D7-B072-95101EC71719Q36878662-1FE643B5-3DA0-40AE-9F9B-5E99E312F08FQ37646903-11EF05DF-FB29-4FD9-AA95-B0DEFE01DB00Q38043397-203D0F46-B33E-43D8-83B0-E7DFB0C11CAAQ38062497-346BA488-DA98-4D37-85FF-16FE99E58006Q38078996-4E042775-DDC9-4C0D-830B-DAA6C095D9B8Q38134106-011B2F29-A7A0-4BE3-BF07-6059DB372829Q38206114-98BC8C80-39EC-443F-869A-9B40B5065D17Q38375953-E3794BFC-A454-427F-9276-9FDA31531BFFQ38503895-0350544D-CE7D-41EC-8369-22FDBA73EE17Q38544077-CB78F025-94DA-43CF-9F0A-D87B3763C4FDQ38600595-66F8F60E-0295-4BC2-AC99-C55584AD6F73Q38684417-C7A1F73B-2E89-43ED-BA92-EDEFA0B763DEQ38694852-5FFA59C3-70DD-4F70-827F-3F1BCB738FC2Q38851586-B55DB222-B526-4263-A12A-6EA3660BCC36Q38931848-B137F287-FF0D-4A4D-8B7B-D0FCA2F2B32EQ39008865-72621306-F816-4126-8154-78813992D59AQ39017669-630B5013-3042-4C78-AB23-068DB4CF7CA1Q39127898-55748355-0B3B-46E0-9D59-9DB1B8B000E9Q39141563-DA4CD228-3148-461A-80C2-947D24F5522AQ41134824-B058D513-C113-4467-B893-00EF890B15E1Q46307966-050EB537-10DB-4C02-82BB-61DA3086456FQ47102988-96DDE251-9DE9-4368-9342-095E635E94E9Q47357545-AB8CA90B-E58F-47E4-853A-00D194844BDDQ48218245-DAC1FAB6-0788-441F-9537-D60D3363EE0EQ48223702-FCEF8516-FB87-4B3D-A54F-A4D09A52AC48Q53520277-1E6AA1D0-AF14-4992-A76E-62FCF217122BQ53807960-A7C51F81-935E-4ACF-8973-AE97B20867AA
P2860
Increased expression of microRNA miR-326 in type 1 diabetic patients with ongoing islet autoimmunity.
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Increased expression of microR ...... th ongoing islet autoimmunity.
@ast
Increased expression of microR ...... th ongoing islet autoimmunity.
@en
Increased expression of microR ...... th ongoing islet autoimmunity.
@nl
type
label
Increased expression of microR ...... th ongoing islet autoimmunity.
@ast
Increased expression of microR ...... th ongoing islet autoimmunity.
@en
Increased expression of microR ...... th ongoing islet autoimmunity.
@nl
prefLabel
Increased expression of microR ...... th ongoing islet autoimmunity.
@ast
Increased expression of microR ...... th ongoing islet autoimmunity.
@en
Increased expression of microR ...... th ongoing islet autoimmunity.
@nl
P2093
P356
P1476
Increased expression of microR ...... th ongoing islet autoimmunity.
@en
P2093
Dorica Cataldo
Fabio Arturo Grieco
Isabella Spagnuolo
Letizia Galleri
P304
P356
10.1002/DMRR.1262
P577
2011-11-01T00:00:00Z